Use of Evidence-Based Therapy for the Prevention of Cardiovascular Events Among Older people

Sage Publications Inc
Publication Type:
Journal Article
Evaluation & The Health Professions, 2010, 33 (3), pp. 276 - 301
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010004316OK.pdf217.23 kB
Adobe PDF
Evidence-based therapies (EBTs) for the prevention of cardiovascular disease (CVD) are reportedly underutilized in older people. The primary purpose of this study was to evaluate the use of EBTs for the prevention of CVD events in older people and secondarily whether a Home Medicines Review (HMR) service by pharmacists predicts the use of these medicines. A retrospective cross-sectional audit of HMR reports pertaining to 608 community-dwelling older people (65 years) was conducted. EBTs considered for this audit included four guideline-recommended therapies for CVD: antithrombotic therapy (warfarin+antiplatelet therapy), b-blockers, statins, and angiotensin agents (angiotensin-converting enzyme inhibitors [ACEI]+angiotensin II receptor blockers [ARBs]).
Please use this identifier to cite or link to this item: